Cargando…
Metabolic manipulation in dilated cardiomyopathy: Assessing the role of trimetazidine
OBJECTIVES: To study the role of metabolic modulator (trimetazidine: TMZ) in dilated cardiomyopathy (DCM). Optimizing altered substrate metabolism in heart failure (HF) with metabolic modulators allows more efficacious energy production from glucose than from free fatty acids. METHODS: 100 patients...
Autores principales: | Jatain, Suman, Kapoor, Aditya, Sinha, Archana, Khanna, Roopali, Kumar, Sudeep, Garg, Naveen, Tewari, Satyendra, Goel, Pravin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143816/ https://www.ncbi.nlm.nih.gov/pubmed/27931551 http://dx.doi.org/10.1016/j.ihj.2016.04.023 |
Ejemplares similares
-
Metabolic manipulation in Dilated Cardiomyopathy: assessing the role of trimetazidine
por: Kapoor, Aditya, et al.
Publicado: (2015) -
Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine
por: Raja, Deep Chandh, et al.
Publicado: (2018) -
Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention–induced myocardial injury
por: Kazmi, Danish H., et al.
Publicado: (2018) -
Metabolic syndrome & Framingham Risk Score: Observations from a coronary angiographic study in Indian patients
por: Khanna, Roopali, et al.
Publicado: (2013) -
Use of strain, strain rate, tissue velocity imaging, and endothelial function for early detection of cardiovascular involvement in young diabetics
por: Kaushik, Atul, et al.
Publicado: (2021)